001     878688
005     20220224125200.0
024 7 _ |a 10.1002/trc2.12032
|2 doi
024 7 _ |a 2128/25589
|2 Handle
024 7 _ |a altmetric:83401915
|2 altmetric
024 7 _ |a pmid:32490142
|2 pmid
024 7 _ |a WOS:000751652300051
|2 WOS
037 _ _ |a FZJ-2020-03006
082 _ _ |a 610
100 1 _ |a Haeger, Alexa
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Effect of a multicomponent exercise intervention on brain metabolism: A randomized controlled trial on Alzheimer's pathology (Dementia‐MOVE)
260 _ _ |a Hoboken, NJ
|c 2020
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1599571927_32472
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a BackgroundPhysical activity has shown a positive impact on aging and neurodegeneration and represents a possible treatment option in cognitive decline. However, its underlying mechanisms and influences on brain pathology remain unclear. Dementia‐MOVE (Multi‐Objective Validation of Exercise) is a randomized‐controlled pilot trial, including 50 patients with amnestic cognitive impairment associated with Alzheimer's pathology, aiming to analyze the effect of physical activity and fitness on disease progression.MethodsDementia‐MOVE is divided into two arms, of either an intervention comprising physical activity, for at least twice a week, combined with a psychoeducational program, or a sole psychoeducational program. Physical activity intervention includes a supervised and unsupervised multimodal concept combining resistance, endurance, coordinative, and aerobic training. The primary outcome is the change of brain metabolism due to physical interventional treatment. Besides metabolic magnetic resonance imaging (MRI) including sodium and phosphorus imaging, resting state functional MRI, T1‐, T2‐weighted and fluid‐attenuated inversion recovery (FLAIR), as well as diffusion‐weighted imaging (DWI) of the brain and whole‐body fat MRI are performed before and after intervention, and will be compared in their sensitivity for the detection of intervention effects. We further assess cognitive performance, neuropsychiatric symptoms, quality of life, fitness, and sleep via questionnaires/interviews and/or fitness trackers, as well as microbiome, under the aspect of Alzheimer's pathology.DiscussionThe aim of Dementia‐MOVE is to investigate the effect of a multimodal exercise program on Alzheimer's pathology under different aspects of the disease. In this context, one of the main aims is the comparison of different MRI methods regarding their responsiveness for the detection of alterations induced by physical activity. As an underlying goal, new treatment and diagnostic options, as well as the exploration of fitness effects on brain structure and metabolism within a whole‐body perspective of Alzheimer's disease are envisaged.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Costa, Ana S.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Romanzetti, Sandro
|0 P:(DE-Juel1)177890
|b 2
|u fzj
700 1 _ |a Kilders, Axel
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Trautwein, Christian
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Haberl, Luisa
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Beulertz, Michael
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Hildebrand, Frank
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Schulz, Jörg B.
|0 P:(DE-Juel1)171786
|b 8
|u fzj
700 1 _ |a Reetz, Kathrin
|0 P:(DE-Juel1)177889
|b 9
|e Corresponding author
|u fzj
773 _ _ |a 10.1002/trc2.12032
|g Vol. 6, no. 1
|0 PERI:(DE-600)2832891-7
|n 1
|p e12032
|t Alzheimer's & dementia / Translational research & clinical interventions Translational research & clinical interventions
|v 6
|y 2020
|x 2352-8737
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/878688/files/trc2.12032.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/878688/files/trc2.12032.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:878688
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)177890
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)171786
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)177889
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-02-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-02-28
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-02-28
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
920 1 _ |0 I:(DE-82)080010_20140620
|k JARA-BRAIN
|l JARA-BRAIN
|x 0
920 1 _ |0 I:(DE-Juel1)INM-11-20170113
|k INM-11
|l Jara-Institut Quantum Information
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-82)080010_20140620
980 _ _ |a I:(DE-Juel1)INM-11-20170113
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21